Cancer Profiling Market Size, Share, And Growth Report 2032

Cancer Profiling Market Size

The global cancer profiling market size was worth around USD 10.82 billion in 2023 and is predicted to grow to around USD 27.45 billion by 2032 with a compound annual growth rate (CAGR) of roughly 10.9% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the cancer profiling market on a global and regional level.

Request Free Sample

Cancer Profiling Market: Overview

Cancer profiling is a technique used as a diagnostic test to detect cancer genetically. This test provides genetic information stored inside cancer or tumor cells. This technique helps in determining the correct action course alongside assisting the doctor to zero on the exact therapeutics needed by the patient, which, in turn, increases the efficacy of the treatment.

According to the WHO (World Health Organization), cancer is the second leading cause of death worldwide. Additionally, it was estimated that about 9.6 million deaths occurred globally in 2018 due to cancer. According to the Cancer Research UK, about 17 million new cancer cases were registered globally in 2018. The globally growing prevalence of cancer is mainly anticipated to drive the growth of the global cancer profiling market. The rise in the adoption of cancer biomarkers for cancer profiling, increase in the number of research activities for cancer treatments, development of various cancer diagnostics techniques, and growth in investments made by governments and other institutions for cancer research and demand for personalized medicines in developed countries are driving the global cancer profiling market. The growing awareness about cancer profiling techniques and increase in efforts by companies to launch new technologies for cancer profiling are also fueling the global market for cancer profiling. However, the dearth of skilled professionals and infrastructure in developing countries may hamper the global cancer profiling market in the future.

Request Free Sample

Cancer Profiling Market: Segmentation

The study provides a decisive view of the cancer profiling market on the basis of technique, technology, cancer type, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032. 

By technique, the market for cancer profiling includes genomics, epigenetics, proteomics, and metabolomics. Genomics dominated the cancer profiling market in 2023, owing to its cost-effectiveness and improved screen time.

Based on technology, the cancer profiling market includes in situ hybridization, PCR, immunohistochemistry, microarray, next-generation sequencing, and others.

By cancer type, the cancer profiling market includes prostate cancer, melanoma cancer, breast cancer, colorectal cancer, lung cancer, and others. The growing prevalence of breast cancer among women is mainly fueling the breast cancer segment.

Based on application, the cancer profiling market includes personalized medicine, oncological diagnostics, research, and others. Personalized medicine is anticipated to show high growth in the future, due to the growing awareness about the advantages of personalized medicines in developed countries and the rising number of research and development activities for personalized medicine.

Cancer Profiling Market: Report Scope

Cancer Profiling Market: Regional Analysis

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. 

By region, North America dominated the global market in 2023 owing to high cancer prevalence, developed healthcare infrastructure, and an increase in the number of cancer-related research activities. Asia Pacific is expected to show the highest CAGR in the upcoming years, owing to the growing cancer prevalence in developing countries like India and China, rising investments by companies and governments in cancer research, and increasing awareness about cancer profiling techniques.

Cancer Profiling Market: Competitive Players

Some key players of the global cancer profiling market are:

• HTG Molecular Diagnostic
• Illumina
• NeoGenomics Laboratories
• QIAGEN
• Caris Life Sciences
• Helomics Corporation
• Oxford Gene Technology
• Genomic Health
• NanoString Technologies
• RiboMed Biotechnologies

The Global Cancer Profiling Market is segmented as follows:

Global Cancer Profiling Market: Technique Analysis

• Genomics
• Proteomics
• Metabolomics
• Epigenetics

Global Cancer Profiling Market: Technology Analysis

• Immunoassay
• Hybridization
• Next-Generation Sequencing
• Mass Spectroscopy
• Others

Global Cancer Profiling Market: Cancer Type Analysis

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Melanoma Cancer
• Others

Global Cancer Profiling Market: Application Analysis

• Personalized Cancer Medicine
• Oncological Diagnostics
• Research
• Others

Global Cancer Profiling Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa